- Home
- AGI vs SNN Comparison
AGI vs SNN Comparison
Compare AGI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGI | SNN |
|---|---|---|
| Founded | 2003 | 1856 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | Precious Metals | Industrial Specialties |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 14.3B |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | AGI | SNN |
|---|---|---|
| Price | $41.00 | $32.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $44.33 | $36.25 |
| AVG Volume (30 Days) | ★ 3.4M | 786.8K |
| Earning Date | 04-29-2026 | 03-02-2026 |
| Dividend Yield | 0.30% | ★ 2.35% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $55.02 | $7.19 |
| Revenue Next Year | $13.09 | $5.36 |
| P/E Ratio | ★ $34.21 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.49 | $23.91 |
| 52 Week High | $55.41 | $38.79 |
Technical Indicators
Market Signals| Indicator | AGI | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 39.49 | 35.08 |
| Support Level | $37.26 | $32.15 |
| Resistance Level | $45.24 | $33.89 |
| Average True Range (ATR) | 2.29 | 0.58 |
| MACD | -1.35 | -0.26 |
| Stochastic Oscillator | 23.30 | 11.21 |
Price Performance
Historical ComparisonAbout AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has four operating segments being Young-Davidson, Island Gold and Magino mines operate in Canada, and the Mulatos mine operates in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.